The Failure of Vytorin and Statins to Improve Cardiovascular Health: Bad Cholesterol Or Bad Theory?
Journal of American Physicians and Surgeons 2008, Fall, 13, 3
-
- $5.99
-
- $5.99
Publisher Description
ABSTRACT The clinical failure of Vytorin in the ENHANCE trial supports the need to reevaluate the efficacy of widespread use of statin drugs for the treatment and prevention of coronary artery disease (CAD).
GENRE
Business & Personal Finance
RELEASED
2008
September 22
LANGUAGE
EN
English
LENGTH
26
Pages
PUBLISHER
Association of American Physicians and Surgeons, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
296.6
KB
Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview)
2008
Selective Serotonin: Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?(Report)
2009
Lessons from Sweden's Universal Health System: Tales from the Health-Care Crypt.
2008
Low-Fat Diet and Chronic Disease Prevention: The Women's Health Initiative and Its Reception.
2007
The Coase Theorem: The Greatest Economic Insight of the 20th Century.
2007
Conviction Without a Crime: A True Story (Viewpoint Essay)
2008